Clinical trial shows possible longer life for dogs with osteosarcomaNovember 1, 2018Fifteen dogs diagnosed with osteosarcoma survived a median time of 415 days after completing canine osteosarcoma immunotherapy, according to a clinical trial by ELIAS Animal Health.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more